Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 274-283

Bentham Science Publishers

Access to resources Recommend Favorite

Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer

By Koukourakis George   Baksevanis Constantinos   Zambatis Haralambos   Gritzapis Angelos   Maltezos Efstratios   Simopoulos Costantinos   Koukourakis Michael  

International Journal of Radiation Biology, Vol. 85, Iss. 1, 2009-01 ,pp. : 96-104

Informa Healthcare

Access to resources Recommend Favorite

The CD95 system and the death of a lymphocyte

By Matiba B.   Mariani S.M.   Krammer P.H.  

Seminars in Immunology, Vol. 9, Iss. 1, 1997-01 ,pp. : 59-68

Academic Press

Access to resources Recommend Favorite

Metallothionein and Fas (CD95) are Expressed in Squamous Cell Carcinoma of the Tongue

By Sundelin K.   Jadner M.   Norberg-Spaak L.   Davidsson A.   Hellquist H.B.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1860-1864

Elsevier

Access to resources Recommend Favorite

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

By Perabo F.G.E.   Mattes R.H.   Wirger A.   Steiner G.   Kamp S.   Schmidt D.   Pegelow K.   von Ruecker A.   Muller S.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 4, 2001-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite